Ho Robert
Insider CIK 1806254 · NLTX Chief Financial Officer · THRD Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 95,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 367,955 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 367,955 | — | $0 | 367,955 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 95,000 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 136,000 | — | $0 | 136,000 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2022-10-25 | 2022-10-27 | 95,000 | — | $0 | 95,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-02-01 | 2022-02-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-08-03 | 2021-08-05 | 190,000 | — | $0 | 190,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2021-03-17 | 2021-03-18 | 6,497 | $11.01 | $71.5K | 21,503 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2021-03-16 | 2021-03-18 | 25,000 | — | $0 | 50,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2021-03-16 | 2021-03-18 | 25,000 | — | $0 | 28,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2020-08-10 | 2020-08-12 | 90,000 | — | $0 | 90,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-16 | 75,000 | — | $0 | 75,000 | SEC↗ |